CRD-B
Crawford & Company
There isn't enough reported data to score CRD-B yet.
HOOD
Robinhood Markets, Inc.
HOOD's fundamentals are mixed, but it looks cheap: trading at 38x earnings, below its usual 51x. Analysts expect strong earnings growth, though they disagree widely on how much.
CRD-B Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
CRD-B's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRD-B.
HOOD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
HOOD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOOD.
CRD-B PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $11.49 | — |
| Cheap | 12x | $8.64 | -25% |
| Fair | 19x | $13.43 | +17% |
| Current | 22x | $11.49 | — |
| Expensive | 29x | $21.04 | +83% |
Historical ranges are pointers, not guarantees.
CRD-B's PE is 22x, but its earnings don't support one, so it isn't a reliable read right now.
HOOD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $81.35 | — |
| Cheap | 37x | $78.84 | -3.1% |
| Current | 38x | $81.35 | — |
| Fair | 51x | $110 | +35% |
| Expensive | 74x | $160 | +96% |
Historical ranges are pointers, not guarantees.
HOOD has the edge over CRD-B in the historical PE scenario, which offers more potential upside but is not a forecast.
CRD-B Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect CRD-B's earnings to grow, with its revenue and profitability holding steady.
HOOD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
HOOD has the edge over CRD-B on the outlook, with more favorable revenue and profitability expectations.
CRD-B Earnings Per Share
CRD-B and HOOD do not have enough comparable growth data to identify a winner.
HOOD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.72 | +26% |
| Q3 2026 | $2.16 | -10% |
| Q2 2026 | $2.26 | +15% |
| Q1 2026 | $2.06 | +18% |
| Q4 2025 | $2.05 | +31% |
| Q3 2025 | $2.40 | +314% |
| Q2 2025 | $1.96 | +513% |
| Q1 2025 | $1.75 | +1150% |
| Q4 2024 | $1.56 | +$2.17 |
HOOD earned $2.16 per share over the past year, down 10% from the year before.
CRD-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $329.9M | -0.9% |
| Q2 2026 | $330M | -1.4% |
| Q1 2026 | $320.1M | -1% |
| Q4 2025 | $320.1M | -11% |
| Q3 2025 | $332.8M | -2.9% |
| Q2 2025 | $334.6M | +2.4% |
| Q1 2025 | $323.3M | +3.3% |
| Q4 2024 | $358.3M | +12% |
CRD-B's revenue grew through 2022 and has held roughly level since: $330M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.3% | +1.1 points |
| Q2 2026 | 6.4% | +1.6 points |
| Q1 2026 | 2.9% | -0.7 points |
| Q4 2025 | -1.3% | -4.6 points |
| Q3 2025 | 6.2% | +1.2 points |
| Q2 2025 | 4.8% | +0.1 points |
| Q1 2025 | 3.6% | +1.6 points |
| Q4 2024 | 3.4% | +3.2 points |
CRD-B's operating margin was 7.3% last quarter, up 1.1 points from the same quarter a year ago, near the top of its range since 2019.
HOOD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +32% |
| Q1 2026 | $1.1B | +15% |
| Q4 2025 | $1.3B | +27% |
| Q3 2025 | $1.3B | +100% |
| Q2 2025 | $989M | +45% |
| Q1 2025 | $927M | +50% |
| Q4 2024 | $1B | +115% |
HOOD has the edge over CRD-B on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | -5.9 points |
| Q2 2026 | 54% | +9.5 points |
| Q1 2026 | 39% | -1.5 points |
| Q4 2025 | 52% | -3.5 points |
| Q3 2025 | 50% | +26 points |
| Q2 2025 | 45% | +17 points |
| Q1 2025 | 40% | +14 points |
| Q4 2024 | 55% | +49 points |
HOOD has the edge over CRD-B on profitability, with a higher operating margin.
CRD-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5M | -83% |
| Q2 2026 | $18.6M | -45% |
| Q1 2026 | $1.4M | +$16.3M |
| Q4 2025 | $46.9M | +26% |
| Q3 2025 | $29.3M | +65% |
| Q2 2025 | $33.6M | +188% |
| Q1 2025 | -$14.9M | +$6.4M |
| Q4 2024 | $37.3M | +9.1% |
CRD-B has the edge over HOOD on cash flow, with more consistent year-over-year improvement.
HOOD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +$2.8B |
| Q2 2026 | $720M | -79% |
| Q1 2026 | $2B | +217% |
| Q4 2025 | -$937M | +$463M |
| Q3 2025 | -$1.6B | -187% |
| Q2 2025 | $3.5B | +6398% |
| Q1 2025 | $642M | +$1.3B |
| Q4 2024 | -$1.4B | -246% |
HOOD's free cash flow was $3B over the past year, up 159% from the year before. Free cash flow isn't a meaningful measure for financial services companies like HOOD.
CRD-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -947K shares |
| 1 year | -3.2% | -1.6M shares |
| 3 years | -2.5% | -1.2M shares |
| 5 years | -10% | -5.4M shares |
| Available history | -10% | -5.5M shares |
CRD-B has the edge over HOOD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.5M |
| Q2 2026 | $3.5M |
| Q1 2026 | $5.5M |
| Q4 2025 | $7.6M |
| Q3 2025 | $3M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $263,000 |
CRD-B spent $30M buying back its own shares over the past year, about nine times what it spent the year before.
HOOD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1M shares |
| 1 year | -0.8% | -6.9M shares |
| 3 years | +1.8% | +15.9M shares |
| 5 years | +292% | +679M shares |
| Available history | +7.2% | +60.8M shares |
HOOD has 911M diluted shares, down 0.8% from a year ago, with $789M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $414M |
| Q1 2026 | $250M |
| Q4 2025 | $100M |
| Q3 2025 | $107M |
| Q2 2025 | $124M |
| Q1 2025 | $322M |
| Q4 2024 | $160M |
HOOD spent $789M buying back its own shares over the past year, up 11% from the year before.
CRD-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 2.0x | Moderate |
| Q4 2024 | 1.9x | Healthy |
CRD-B's net debt is about 1.6 years of its operating earnings (EBITDA), about the same as a year ago. Net leverage isn't a meaningful measure for financial services companies like CRD-B.
HOOD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -3.3x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
HOOD has the edge over CRD-B on leverage, with a lower net debt burden relative to earnings.
CRD-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 35.7 | Neutral |
CRD-B's weekly RSI is 52 (neutral) and its Stochastic is 36 (neutral).
HOOD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 9.5 | Oversold |
HOOD's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
CRD-B PE vs Financial Services Sector
| Metric | CRD-B | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 13x | 65% above |
| PE % | 63 | 63 | Same percentile |
CRD-B has the edge over HOOD on valuation relative to its sector.
HOOD PE vs Financial Services Sector
| Metric | HOOD | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 22 | 66 | 44 pts below |
HOOD is trading at 38x earnings, a 189% premium to the Financial Services sector's median of 13x.
CRD-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.8 | 2.5% below |
| 20 week MA | $11.5 | 0.3% below |
| 50 week MA | $10.9 | 5.6% above |
| 100 week MA | $10.9 | 5.4% above |
| 200 week MA | $10.4 | 10% above |
CRD-B has the edge over HOOD on trend strength, trading above more of its moving averages.
HOOD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.8 | 17% below |
| 20 week MA | $102.2 | 20% below |
| 50 week MA | $95.4 | 15% below |
| 100 week MA | $88.5 | 8.1% below |
| 200 week MA | $52.1 | 56% above |
HOOD has fallen below most of its moving averages, though it's still 56% above its 200-week average.
CRD-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.1 | $7.49 | -33% |
| 2021 | $7.49 | $7.51 | +0.3% |
| 2022 | $7.51 | $5.55 | -26% |
| 2023 | $5.55 | $13.2 | +137% |
| 2024 | $13.2 | $11.5 | -13% |
| 2025 | $11.5 | $11.9 | +3.6% |
| 2026 YTD | $11.9 | $11.5 | -3.2% |
CRD-B has the edge over HOOD on returns for 2026, with the stronger performance.
HOOD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $35.2 | $18.9 | -46% |
| 2022 | $18.9 | $7.95 | -58% |
| 2023 | $7.95 | $12.7 | +60% |
| 2024 | $12.7 | $39.0 | +206% |
| 2025 | $39.0 | $118.1 | +203% |
| 2026 YTD | $118.1 | $81.4 | -31% |
HOOD's yearly returns have swung widely, from +206% in 2024 to −58% in 2022. It's down 31% so far in 2026.